Prevalence of Raynaud's phenomenon in a healthy Greek population

Annals of the Rheumatic Diseases

Volumn 59, Issue 3, 2000, Pages 206-210

  Voulgari, Paraskevi V ^a   Alamanos, Yannis ^b   Papazisi, Damiani ^a   Christou, Konstantinos ^a   Papanikolaou, Christina ^a   Drosos, Alexandros A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COLD EXPOSURE; CULTURAL FACTOR; DEMOGRAPHY; ENVIRONMENTAL FACTOR; FEMALE; GREECE; HUMAN; HYPEREMIA; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL HEALTH; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; VASOMOTOR REFLEX;

ADULT; AGE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PREVALENCE; RAYNAUD DISEASE; RISK FACTORS; SEX DISTRIBUTION;

EID: 0034027120     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.3.206     Document Type: Article

References (37)

1. 1 Klippel JH, Dieppe PA. Rheumatology. London: Mosby 1994;6.8.1-3.
2. 2 Klippel JH, Weyand CM, Wortmann RL. Primer on the rheumatic diseases. 11th ed. Atlanta, GA: Arthritis Foundation 1997:268.
3. 3 Brennan P, Silman A, Black C, Bernstein R, Coppock J, Maddison P, et al. Validity and reliability of three methods used in the diagnosis of Raynaud's phenomenon. The UK Scleroderma Study Group. Br J Rheumatol 1993;32:357-61.
4. 4 Skopouli FN, Talal A, Galanopoulou V, Tsampoulas CG, Drosos AA, Moutsopoulos HM. Raynaud's phenomenon in primary Sjögren's syndrome. J Rheumatol 1990;17:618-20.
5. 5 Wigley FM, Flavahan NA. Raynaud's phenomenon. Rheum Dis Clin North Am 1996;22:765-81.
6. 6 Silman A, Holligan S, Brennan P, Maddison P. Prevalence of symptoms of Raynaud's phenomenon in general practice. BMJ 1990;22:590-2.
7. 7 Heslop J, Coggon D, Acheson ED. The prevalence of intermittent digital ischaemia (Raynaud's phenomenon) in a general practice. J Roy Coll Gen Pract 1983;33:85-9.
8. 8 Maricq HR, Weinrich MC, Keil JE, Le Roy EC. Prevalence of Raynaud's phenomenon in the general population. A preliminary study by questionnaire. J Chron Dis 1986;39: 423-7.
9. 9 Weinrich MC, Maricq HR, Keil JE, McGregor AR, Diat F. Prevalence of Raynaud phenomenon in the adult population of South Carolina. J Clin Epidemiol 1990;43:1343-9.
10. 10 Walker DD, Jones B, Ogston S, Tasker EG, Robinson AJ. A study of white finger in the gas industry. BMJ 1985;42: 672-7.
11. 11 Leppert J, Aberg H, Ringqvist I, Sörensson S. Raynaud phenomenon in a female population: prevalence and association with other conditions. Angiology 1987;38:871-7.
12. 12 Olsen N, Nielsen SL. Prevalence of primary Raynaud's phenomenon in young females. Scand J Clin Lab Invest 1978; 37:761-4.
13. 13 Iwata H, Makimo S, Miyashita K. Prevalence of Raynaud's phenomenon in individuals not using vibrating tools. Sangyo Igaku 1987;20:500-3.
14. 14 Harada K, Ueda A, Takegata S. Prevalence of Raynaud's phenomenon in Japanese males and females. J Clin Epidemiol 1991;44:649-55.
15. 15 Bartelink ML, Wollersheim M, Van de Lisdonk E, Spruijt R, Van Weel C. Prevalence of Raynaud's phenomenon. Neth J Med 1992;41:149-52.
16. 16 Riera G, Vilardell M, Vaqué J, Fonollosa V, Bermejo B. Prevalence of Raynaud's phenomenon in a healthy Spanish population. J Rheumatol 1993;20:66-9.
17. 17 Maricq HR, Carpentier PH, Weinrich MC, Keil JE, Franco A, Drouet P, et al. Geographic variation in the prevalence of Raynaud's phenomenon: Charleston, SC, USA, vs Tarentaise, Savoie, France. J Rheumatol 1993;20:70-6.
18. 18 Valter I, Maricq HR. Prevalence of Raynaud phenomenon in Tartu and Tartumaa, southern Estonia. Scand J Rheumatol 1997;26:117-24.
19. 19 O'Keefee ST, Tsapatsaris NP, Beetham WP Jr. Color chart assisted diagnosis of Raynaud's phenomenon in an unselected hospital employee population. J Rheumatol 1992;19:1415-17.
20. 20 Maricq HR, Carpentier PH, Weinrich MC, Keil JE, Palesch Y, Bito C, et al. Geographic variation in the prevalence of Raynaud's phenomenon: A 5 region Comparison. J Rheumatol 1997;24:879-89.
21. 21 Yu ZS, Chao H, Qiao L, Qian DS, Ye YH. Epidemiologic survey of vibration syndrome among riveters, chippers and grinders in the rail road system of the People's Republic of China. Scand J Work Environ Health 1986;12:289-92.
22. 22 Kaminski M, Bourgine M, Zins M, Touranchet A, Verger C. Risk factors of Raynaud's phenomenon among workers in poultry slaughterhouses and canning factories. Int J Epidemiol 1997;26:371-80.
23. 23 Fraenkel L, Zhang Y, Chaisson CE, Evans SP, Wilson PWF, Felson DT. The association of estrogen replacement therapy and the Raynaud phenomenon in postmenopausal women. Ann Intern Med 1998;129:208-11.
24. 24 Bartelink ML, Wollersheim H, Van de Lisdonk E, Thien T. Raynaud's phenomenon: subjective influence of female sex hormones. Int Angiol 1992;11:309-15.
25. 25 Bartelink ML, van de Lisdonk E, van den Hoogen H, Woller Sheim H, van Weel C. Migraine in family practice: prevalence and influence of sex hormonal status. Fam Med 1993;25:331-6.
26. 26 O'Keefee ST, Tsapatsaris NP, Beetham WP Jr. Association between Raynaud's phenomenon and migraine in a random population of hospital employees. J Rheumatol 1993;20:1187-8.
27. 27 Keil JE, Maricq HR, Weinrich MC, McGregor AR, Diat F. Demographic, social and clinical correlates of Raynaund phenomenon. Int J Epidemiol 1991;19:221-4.
28. 28 Di Giacomo RA, Kremer JM, Shah DM. Fish oil supplementation in patients with Raynaud's phenomenon: A double-blind controlled prospective study. Am J Med 1989;86:158.
29. 29 Tzioufas AG, Manoussakis MN, Costello R, Silis M, Papadopoulos NM, Moutsopoulos HM. Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with primary Sjögren's syndrome. Arthritis Rheum 1986;29:1098-104.
30. 30 De Trafford JC, Lafferty K, Potter CE, Roberts VC, Cotton LT. An epidemiological survey of Raynaud's phenomenon. Eur J Vasc Surg 1988;2:167-70.
31. 31 Coffman JD, Cohen RA. Alpha-2 adrenergic and 5-HT 2 receptor hypersensitivity in Raynaud's phenomenon. J Vasc Med Biol 1990;2:100-6.
32. 32 Solerte SB, Fioravanti M, Spinillo A, Ferrari E, Guaschino S. Association between hormonal and haemorheological changes during the menstrual cycle in healthy women. Br J Obstet Gynaecol 1988;95:1305-8.
33. 33 Levine JD, Taiwo YO. Beta-estradiol induced catecholamine-sensitive hyperalgesia: a contribution to pain in Raynaud's phenomenon. Brain Res 1989;487: 143-7.
34. 34 Vayssairat M, Abuaf N, Baudot N, Deschamps A, Gaitz JP. Abnormal IgG cardiolipin antibody titers in patients with Raynaud's phenomenon and/or related disorders: prevalence and clinical significance. J Am Acad Dermatol 1998; 38:555-8.
35. 35 Harper FE, Maricq HR, Turner RE, Lidman RW, Leroy EC. A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report. Am J Med 1982;72:883-8.
36. 36 Houtman PM, Kallemberg CG, Fidler V, Wouda AA. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. J Rheumatol 1986;13:556-63.
37. 37 Gemne G. Pathophysiology and multifactorial etiology of acquired vasospastic disease (Raynaud syndrome) in vibration-exposed workers. Scand J Work Environ Health 1982;8:243-9.